Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/1996
06/11/1996US5525232 Method for entrapment of cationic species in lemellar vesicles
06/11/1996CA2164777A1 Pharmaceutical, orally applicable composition
06/11/1996CA2054664C Hydrolytic stabilizer for unstable organic ions
06/07/1996CA2161762A1 Water-in-oil-in-water compositions
06/06/1996WO1996016671A1 New antithrombotic formulation, process for its manufacturing, and use thereof
06/06/1996WO1996016670A1 New therapeutical utilization of superoxide dismutases
06/06/1996WO1996016659A1 Cyclodextrins as suspending agents for pharmaceutical suspensions
06/06/1996WO1996016658A1 Indolocarbazole derivative preparation
06/06/1996WO1996016643A1 Drug releasing surgical implant or dressing material
06/06/1996WO1996016642A1 Matrix type patch preparation
06/06/1996WO1996016641A1 Transdermal preparation containing a loratidine metabolite with antihistaminic activity
06/06/1996WO1996016640A1 Oral compositions of h2-antagonists
06/06/1996WO1996016639A1 Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants
06/06/1996WO1996016638A1 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants
06/06/1996CA2206459A1 New antithrombotic formulation, process for its manufacturing, and use thereof
06/06/1996CA2206348A1 Cyclodextrins as suspending agents for pharmaceutical suspensions
06/06/1996CA2206303A1 Matrix type patch formulation
06/06/1996CA2206259A1 Drug releasing surgical implant or dressing material
06/06/1996CA2206142A1 New therapeutical utilization of superoxide dismutases
06/06/1996CA2205351A1 Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants
06/05/1996EP0714665A2 Osteogenic devices
06/05/1996EP0714661A1 Process for the preparation of tablets containing molsidomine
06/05/1996EP0714656A1 Capsule shell compositions and their use
06/05/1996EP0714415A1 Aqueous copolymer dispersions
06/05/1996EP0714411A1 Bioadhesive starches and process for their preparation
06/05/1996EP0714407A1 Composition and methods using nitroxides to avoid oxygen toxicity
06/05/1996EP0714316A1 Implantable drug delivery means
06/05/1996EP0714308A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
06/05/1996EP0714304A1 Therapeutic system for treating psoriasis
06/05/1996EP0714300A1 Methods for modulating the human sexual response
06/05/1996EP0714297A1 Novel 1,2-dithiin antiinfective agents
06/05/1996EP0714289A1 Bioadhesive emulsion preparations for enhanced drug delivery
06/05/1996EP0714283A1 Personal cleansing compositions
06/05/1996EP0555229B1 Accumulation of amino acids and peptides into liposomes
06/05/1996EP0553121B1 Aqueous emulsion and aerosol delivery system using same
06/05/1996DE4442999A1 Pharmazeutische Zusammensetzung mit einem aktiven Loratidin-Metaboliten A pharmaceutical composition comprising an active loratidine metabolite
06/05/1996DE19501022C1 Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung Transdermal therapeutic system for administration of (S) -3-methyl-5- (1-methyl-2-pyrrolidenyl) isoxazole or a pharmaceutically acceptable salt thereof and process for its preparation
06/05/1996CN1124014A Solubilizing agent and external preparation containing the same
06/05/1996CN1123793A Non-reducing oligosaccharide and its production and use
06/05/1996CN1123698A Swine WBC interferon injection and its preparation
06/05/1996CN1123695A Preparation of Paoxuanling for curing tinea
06/05/1996CN1123694A Health-care cigarette made from fig-leaves and its manufacture
06/05/1996CN1123691A Zengzhiling capsule for intelligence development and its production
06/05/1996CN1123690A Naoxuekang capsule for curing cerebrovascular disease and its production
06/05/1996CN1123686A Spraying agent for stopping pains
06/05/1996CN1123682A Kidney-nourishing and bone-strengthening pill and its preparation
06/05/1996CN1123680A Effective health-care product for deficiency of the kidney, spleen and lung and its production
06/05/1996CN1123676A Hypotensor
06/05/1996CN1123675A Health-care medicine for recovery from fatigue
06/05/1996CN1123673A Fengshiqing for weathering rheumatism (external use)
06/05/1996CN1123671A Medicine for curing nephritis
06/05/1996CN1123670A Quick results liquor for stopping the itching made from jasmine and its production
06/05/1996CN1123666A Injection for curing cystic and its producing technique
06/05/1996CN1123665A Long-effect and broad-spectrum antibiotic granules and its production
06/05/1996CN1123662A Special chicken-disease injection and its production
06/05/1996CN1123660A Preparation of dried Chinese medicine decoction
06/04/1996US5523348 Method of preparing collagen-polymer conjugates
06/04/1996US5523316 Intraocular irrigating solution containing agent for controlling IOP
06/04/1996US5523289 Renin inhibitor
06/04/1996US5523118 Polyurethane; permeable barrier
06/04/1996US5523099 Stability, reduced sweetness, appropriate viscosity, non-crystallizing and less fermentabiity; foods, beverages, cosmetics and drugs
06/04/1996US5523095 Controlled release matrix system using cellulose acetate/polyvinylpyrrolidone blends
06/04/1996US5523094 Aqueous mixture of alfuzosin, organic solvent and absorption promoter
06/04/1996US5523093 Gels in the form of highly hydrated self-supporting film, the process for their preparation, and their use in the therapy of cutaneous lesions and/or pathologies
06/04/1996US5523091 Containing silicone, gelling agent, emulsifier
06/04/1996US5523082 Dissolving bromocriptine(or salt) in methanol, dilution with mixture of water and polyvinyl pyrrolidone, freeze drying the mixture, then redissolving residue in solution of polyoxyethylene glycol and unsaturated carboxylic acid
06/04/1996CA2019863C Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
05/1996
05/30/1996WO1996016179A1 Enzyme gene therapy catalysing prodrug extracellular conversion
05/30/1996WO1996016075A1 Antibiotic cryptdin peptides and methods of their use
05/30/1996WO1996015826A1 Composition and method for enhancing electrotransport agent delivery
05/30/1996WO1996015815A1 Microcapsules, method of making and their use
05/30/1996WO1996015814A1 Preparation of hollow microcapsules
05/30/1996WO1996015793A1 Percutaneously absorbable preparation
05/30/1996WO1996015790A1 Lubeluzole intravenous solutions
05/30/1996WO1996015786A2 Oral compositions containing ondansetron
05/30/1996WO1996015785A1 Freeze-dried ondansetron compositions
05/30/1996WO1996015778A1 Polynucleotide compositions
05/30/1996WO1996015776A1 Percutaneously absorbable patch
05/30/1996WO1996015775A1 Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
05/30/1996WO1996015774A1 Methods and apparatus for making liposomes containing hydrophobic drugs
05/30/1996WO1996015773A1 Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds
05/30/1996WO1996015771A1 Prophylactic and therapeutic treatment of skin sensitization and irritation
05/30/1996WO1996015669A1 Prophylactic treatment of allergic contact dermatitis
05/30/1996DE4441763A1 Treatment of hepatic encephalopathy with salt of branched aminoacid
05/30/1996CA2205920A1 Prophylactic treatment of allergic contact dermatitis
05/30/1996CA2205860A1 Prophylactic and therapeutic treatment of skin sensitization and irritation
05/30/1996CA2205606A1 Lubeluzole intravenous solutions
05/30/1996CA2205593A1 Enzyme gene therapy catalysing prodrug extracellular conversion
05/30/1996CA2205500A1 Methods and apparatus for making liposomes containing hydrophobic drugs
05/30/1996CA2205486A1 Polynucleotide compositions
05/30/1996CA2204519A1 Percutaneously absorbable patch
05/30/1996CA2181364A1 Preparation for percutaneous absorption
05/29/1996EP0713699A2 Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
05/29/1996EP0713697A1 Analgesic anti-inflammatory adhesive preparations
05/29/1996EP0713696A1 Topical application product containing a lipase and a precursor of hydroxyacid
05/29/1996EP0713390A1 Gelatin capsules containing a highly concentrated acetaminophen solution
05/29/1996EP0713389A1 Hydrolyzed gelatin as a flavor enhancer in a chewable tablet
05/29/1996EP0713388A1 A method for high loading of vesicles with biopolymeric substances
05/29/1996EP0713387A1 A method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
05/29/1996EP0713386A1 Spray formulation having a cooling effect
1 ... 2698 2699 2700 2701 2702 2703 2704 2705 2706 2707 2708 2709 2710 2711 2712 2713 2714 2715 2716 2717 2718 ... 2991